HEADER PROTEIN BINDING 02-MAR-05 1Z0Q TITLE AQUEOUS SOLUTION STRUCTURE OF THE ALZHEIMER'S DISEASE ABETA PEPTIDE TITLE 2 (1-42) COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALZHEIMER'S DISEASE AMYLOID; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: BETA-PEPTIDE; COMPND 5 SYNONYM: AMYLOID BETA A4 PROTEIN, BETA-APP, BETA-AMYLOID PROTEIN, COMPND 6 BETA-APP42; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THE PEPTIDE WAS PREPARED BY SOLID-PHASE SYNTHESIS. SOURCE 4 THE SEQUENCE OF THE PEPTIDE IS NATURALLY FOUND IN HOMO SAPIENS SOURCE 5 (HUMAN). KEYWDS AMYLOID BETA PEPTIDE, HELIX-KINK-HELIX, ALZHEIMER'S DISEASE, 30 KEYWDS 2 STRUCTURES, PROTEIN BINDING EXPDTA SOLUTION NMR NUMMDL 30 AUTHOR S.TOMASELLI,V.ESPOSITO,P.VANGONE,N.A.VAN NULAND,A.M.BONVIN, AUTHOR 2 R.GUERRINI,T.TANCREDI,P.A.TEMUSSI,D.PICONE REVDAT 3 02-MAR-22 1Z0Q 1 REMARK REVDAT 2 24-FEB-09 1Z0Q 1 VERSN REVDAT 1 23-MAY-06 1Z0Q 0 JRNL AUTH S.TOMASELLI,V.ESPOSITO,P.VANGONE,N.A.VAN NULAND,A.M.BONVIN, JRNL AUTH 2 R.GUERRINI,T.TANCREDI,P.A.TEMUSSI,D.PICONE JRNL TITL THE ALPHA-TO-BETA CONFORMATIONAL TRANSITION OF ALZHEIMER'S JRNL TITL 2 ABETA-(1-42) PEPTIDE IN AQUEOUS MEDIA IS REVERSIBLE: A STEP JRNL TITL 3 BY STEP CONFORMATIONAL ANALYSIS SUGGESTS THE LOCATION OF JRNL TITL 4 BETA CONFORMATION SEEDING JRNL REF CHEMBIOCHEM V. 7 257 2006 JRNL REFN ISSN 1439-4227 JRNL PMID 16444756 JRNL DOI 10.1002/CBIC.200500223 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DYANA 1.5 REMARK 3 AUTHORS : GUNTERT REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1Z0Q COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 04-MAR-05. REMARK 100 THE DEPOSITION ID IS D_1000032151. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 300 REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 2MM BETA PEPTIDE (TFA REMARK 210 PRETREATED); 70% H2O, 30% REMARK 210 HEXAFLUOROISOPROPANOL-D2 REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D TOCSY; 2D NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 400 MHZ; 500 MHZ; 600 MHZ; 750 REMARK 210 MHZ REMARK 210 SPECTROMETER MODEL : DRX; AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 1.5, XWINNMR 3.0, REMARK 210 NMRVIEW 5.0.4, DYANA 1.5 REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 30 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 25 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HIS A 13 H LYS A 16 1.12 REMARK 500 O LEU A 17 H PHE A 20 1.24 REMARK 500 O VAL A 18 H GLU A 22 1.37 REMARK 500 O TYR A 10 H HIS A 14 1.41 REMARK 500 O ASP A 7 H GLU A 11 1.55 REMARK 500 O LYS A 28 H ILE A 31 1.58 REMARK 500 O HIS A 13 N LYS A 16 2.07 REMARK 500 O LEU A 17 N PHE A 20 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ALA A 2 -138.39 -133.84 REMARK 500 1 GLU A 3 -45.45 -131.18 REMARK 500 1 HIS A 6 -71.73 -102.11 REMARK 500 1 ASP A 7 -28.26 -37.04 REMARK 500 1 TYR A 10 -44.59 -138.35 REMARK 500 1 GLU A 11 -73.33 -45.93 REMARK 500 1 HIS A 13 -72.17 -79.73 REMARK 500 1 HIS A 14 -58.02 -18.98 REMARK 500 1 GLN A 15 -17.41 -42.05 REMARK 500 1 LYS A 16 -49.11 -26.41 REMARK 500 1 PHE A 20 -68.11 -98.10 REMARK 500 1 ASN A 27 -58.05 -159.36 REMARK 500 1 LEU A 34 -31.87 -37.39 REMARK 500 1 VAL A 36 -14.95 65.69 REMARK 500 1 VAL A 40 -173.87 47.46 REMARK 500 1 ILE A 41 164.50 -42.98 REMARK 500 2 ALA A 2 117.41 78.79 REMARK 500 2 PHE A 4 -31.46 70.61 REMARK 500 2 HIS A 6 -74.66 -77.95 REMARK 500 2 TYR A 10 -61.67 -97.52 REMARK 500 2 HIS A 14 -52.60 -22.43 REMARK 500 2 GLN A 15 -19.12 -44.48 REMARK 500 2 LYS A 16 -48.95 -29.10 REMARK 500 2 LEU A 17 -18.79 -141.41 REMARK 500 2 PHE A 19 -16.34 -46.16 REMARK 500 2 PHE A 20 -70.48 -99.79 REMARK 500 2 VAL A 24 -65.53 -100.78 REMARK 500 2 SER A 26 -96.88 -88.13 REMARK 500 2 ASN A 27 -84.13 172.87 REMARK 500 2 LYS A 28 -78.22 -146.08 REMARK 500 2 ALA A 30 -7.39 -58.81 REMARK 500 2 ILE A 32 -90.96 -135.05 REMARK 500 2 VAL A 36 -13.52 66.24 REMARK 500 2 VAL A 39 -25.52 79.63 REMARK 500 2 VAL A 40 102.43 -32.90 REMARK 500 2 ILE A 41 162.44 -44.65 REMARK 500 3 ALA A 2 -138.55 -128.69 REMARK 500 3 GLU A 3 -50.16 80.62 REMARK 500 3 HIS A 6 -94.11 -63.62 REMARK 500 3 TYR A 10 -60.84 -98.19 REMARK 500 3 HIS A 13 -72.02 -85.64 REMARK 500 3 HIS A 14 -58.24 -23.50 REMARK 500 3 GLN A 15 -9.04 -48.46 REMARK 500 3 LYS A 16 -36.42 -29.96 REMARK 500 3 LEU A 17 -15.07 -154.30 REMARK 500 3 PHE A 19 -16.99 -48.72 REMARK 500 3 PHE A 20 -65.45 -94.70 REMARK 500 3 ASN A 27 -72.43 -173.59 REMARK 500 3 ALA A 30 11.50 89.26 REMARK 500 3 ILE A 32 -52.05 80.83 REMARK 500 REMARK 500 THIS ENTRY HAS 421 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 1Z0Q A 1 42 UNP P05067 A4_HUMAN 672 713 SEQRES 1 A 42 ASP ALA GLU PHE ARG HIS ASP SER GLY TYR GLU VAL HIS SEQRES 2 A 42 HIS GLN LYS LEU VAL PHE PHE ALA GLU ASP VAL GLY SER SEQRES 3 A 42 ASN LYS GLY ALA ILE ILE GLY LEU MET VAL GLY GLY VAL SEQRES 4 A 42 VAL ILE ALA HELIX 1 1 TYR A 10 GLU A 22 1 13 HELIX 2 2 LYS A 28 ILE A 32 5 5 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1